Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-027189

scPharmaceuticals Inc. · SCPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Nov 21, 2017
Accepted (ET)
Nov 21, 2017 · 7:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604950

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Nov 21, 2017C1,483,107—A1,483,107Iby 5AM Ventures IV, L.P.
Common StockF3,F2Nov 21, 2017C1,011,623—A2,494,730Iby 5AM Ventures IV, L.P.
Common StockF2Nov 21, 2017P628,572$14.00A3,123,302Iby 5AM Ventures IV, L.P.
Common StockF4,F2Nov 21, 2017C61,795—A61,795Iby 5AM Co-Investors IV, L.P.
Common StockF5,F2Nov 21, 2017C42,150—A103,945Iby 5AM Co-Investors IV, L.P.
Common StockF2Nov 21, 2017P26,190$14.00A130,135Iby 5AM Co-Investors IV, L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF2,F6—Nov 21, 2017C10,649,003D——Common Stock1,483,1070I
Series B Preferred StockF2,F6—Nov 21, 2017C7,263,649D——Common Stock1,011,6230I
Series A Preferred StockF2,F6—Nov 21, 2017C443,708D——Common Stock61,7950I
Series B Preferred StockF2,F6—Nov 21, 2017C302,652D——Common Stock42,1500I

Explanation of responses